Neoadjuvant chemotherapy in high-risk soft tissue sarcomas: final results of a randomized trial from Italian (ISG), Spanish (GEIS), French (FSG), and Polish (PSG) …

A Gronchi, E Palmerini, V Quagliuolo… - Journal of Clinical …, 2020 - ascopubs.org
PURPOSE To determine whether the administration of histology-tailored neoadjuvant
chemotherapy (HT) was superior to the administration of standard anthracycline plus …

Neoadjuvant chemotherapy in high-risk soft tissue sarcomas: Final results of a randomized trial from Italian (ISG), Spanish (GEIS), French (FSG), and Polish (PSG) …

A Gronchi, E Palmerini, V Quagliuolo… - JOURNAL OF …, 2020 - cris.unibo.it
PURPOSE To determine whether the administration of histology-tailored neoadjuvant
chemotherapy (HT) was superior to the administration of standard anthracycline plus …

Neoadjuvant Chemotherapy in High-Risk Soft Tissue Sarcomas: Final Results of a Randomized Trial From Italian (ISG), Spanish (GEIS), French (FSG), and Polish …

A Gronchi, E Palmerini, V Quagliuolo… - Journal of Clinical …, 2020 - europepmc.org
Purpose To determine whether the administration of histology-tailored neoadjuvant
chemotherapy (HT) was superior to the administration of standard anthracycline plus …

Neoadjuvant Chemotherapy in High-Risk Soft Tissue Sarcomas: Final Results of a Randomized Trial From Italian (ISG), Spanish (GEIS), French (FSG), and Polish …

A Gronchi, E Palmerini, V Quagliuolo… - JOURNAL OF …, 2020 - research.unipd.it
To determine whether the administration of histology-tailored neoadjuvant chemotherapy
(HT) was superior to the administration of standard anthracycline plus ifosfamide …

Neoadjuvant chemotherapy in high-risk soft tissue sarcomas: Final results of a randomized trial from Italian (ISG), Spanish (GEIS), French (FSG), and Polish (PSG) …

A Gronchi, E Palmerini, V Quagliuolo, JM Broto… - JOURNAL OF …, 2020 - air.unimi.it
PURPOSE To determine whether the administration of histology-tailored neoadjuvant
chemotherapy (HT) was superior to the administration of standard anthracycline plus …

Neoadjuvant Chemotherapy in High-Risk Soft Tissue Sarcomas: Final Results of a Randomized Trial From Italian (ISG), Spanish (GEIS), French (FSG), and Polish …

A Gronchi, E Palmerini, V Quagliuolo, JM Broto… - Journal of Clinical …, 2020 - cir.nii.ac.jp
抄録< jats: sec>< jats: title> PURPOSE</jats: title>< jats: p> To determine whether the
administration of histology-tailored neoadjuvant chemotherapy (HT) was superior to the …

Neoadjuvant Chemotherapy in High-Risk Soft Tissue Sarcomas: Final Results of a Randomized Trial From Italian (ISG), Spanish (GEIS), French (FSG), and Polish …

A Gronchi, E Palmerini, V Quagliuolo… - Journal of clinical …, 2020 - pubmed.ncbi.nlm.nih.gov
Purpose To determine whether the administration of histology-tailored neoadjuvant
chemotherapy (HT) was superior to the administration of standard anthracycline plus …

Neoadjuvant Chemotherapy in High-Risk Soft Tissue Sarcomas: Final Results of a Randomized Trial From Italian (ISG), Spanish (GEIS), French (FSG), and Polish …

A Gronchi, E Palmerini, V Quagliuolo, J Martín-Broto… - 2020 - digital.csic.es
[Patients and methods] This was a randomized, open-label, phase III trial. Patients had
localized high-risk STS (grade 3; size,≥ 5 cm) of an extremity or trunk wall, belonging to one …